Imugene Ltd.

Imugene Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0
Market Cap
AUD54.15 M
Shares Outstanding
3.61 B
Public Float
3.03 B

Profile

Address
62 Lygon Street
Carlton Victoria (VIC) 3053
Australia
Employees -
Website http://www.imugene.com
Updated 07/08/2019
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Carlton, Australia.

Financials

View All

Leslie Chong
Chief Executive Officer, Director & MD
Charles Edwyn Walker
Non-Executive Director